Tag: Pediatrics
-
Northwestern Investigates COVID-19: Omicron, Vaccines, Pediatric Complications
Northwestern Medicine investigators have continued to examine COVID-19, from the impact of prone positioning during treatment to vaccine protection against the Omicron variant in children.
-
First Potential Immunization Against RSV for Healthy Infants Found Highly Effective in Phase 3 Trial
A new drug has been shown to be highly effective against pediatrics infections caused by respiratory syncytial virus (RSV).
-
Northwestern Investigates COVID-19: Omicron, Children and Pandemic’s Impact on Sexual Minorities
Northwestern Medicine investigators continue to study the COVID-19 pandemic, from the biological mechanisms of disease and infection patterns to the pandemic’s impact on women and sexual and gender minorities.
-
Gene Therapy Promotes Transfusion Independence for Severe Beta-Thalassemia
A novel gene therapy promoted transfusion independence in more than 90 percent of adult and pediatric patients with transfusion-dependent beta-thalassemia, according to a recent clinical trial published in The New England Journal of Medicine.
-
Genome Editing Made Possible on Cells Lining Blood Vessel Walls
The laboratory of YouYang Zhao, PhD, developed a unique nanoparticle to deliver genome editing technology, including CRISPR/Cas9, to vascular endothelial cells.
-
County-Level Poverty Associated with Risk of Gun Death in Children
Living in U.S. counties with higher concentrations of poverty was associated with increased risk of firearm-related deaths among children and young adults, according to a recent study.
-
NUPOC Students Create Teddy Bear Braces for Lurie Children’s Patients
On November 5, students in the Master of Prosthetics & Orthotics (MPO) program through Northwestern’s Prosthetics-Orthotics Center constructed more than 50 braces for teddy bears gifted to pediatric patients at Ann & Robert H. Lurie Children’s Hospital.
-
Inge Joins Lurie Children’s Hospital as Surgeon-in-Chief
Ann & Robert H. Lurie Children’s Hospital of Chicago has recruited an internationally recognized surgeon-scientist, Thomas H. Inge, MD, PhD, as the hospital’s next surgeon-in-chief.
-
Advancing Treatment for B-cell Acute Lymphoblastic Leukemia
Tisagenlecleucel, a chimeric antigen receptor (CAR) T-cell immunotherapy, demonstrated safety and efficacy in pediatric patients with relapsed and refractory B-cell acute lymphoblastic leukemia, according to recent findings.
-
New Genetic Mutations Linked to Neurodevelopmental Disease
Northwestern Medicine scientists have characterized several variants of the gene GRIK2 that cause nonsyndromic neurodevelopmental disorder.
